Tsunekuni, K.; Kawakami, H.; Matsuoka, K.; Nagase, H.; Mitani, S.; Nakagawa, K.
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model. J. Clin. Med. 2020, 9, 4050.
https://doi.org/10.3390/jcm9124050
AMA Style
Tsunekuni K, Kawakami H, Matsuoka K, Nagase H, Mitani S, Nakagawa K.
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model. Journal of Clinical Medicine. 2020; 9(12):4050.
https://doi.org/10.3390/jcm9124050
Chicago/Turabian Style
Tsunekuni, Kenta, Hisato Kawakami, Kazuaki Matsuoka, Hideki Nagase, Seiichiro Mitani, and Kazuhiko Nakagawa.
2020. "Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model" Journal of Clinical Medicine 9, no. 12: 4050.
https://doi.org/10.3390/jcm9124050
APA Style
Tsunekuni, K., Kawakami, H., Matsuoka, K., Nagase, H., Mitani, S., & Nakagawa, K.
(2020). Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model. Journal of Clinical Medicine, 9(12), 4050.
https://doi.org/10.3390/jcm9124050
